140 related articles for article (PubMed ID: 3829049)
1. Criteria for selecting monoclonal antibodies with respect to accumulation in melanoma tissue.
Matzku S; Brüggen J; Bröcker EB; Sorg C
Cancer Immunol Immunother; 1987; 24(2):151-7. PubMed ID: 3829049
[TBL] [Abstract][Full Text] [Related]
2. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.
Temponi M; Fawwaz RA; Kekish U; Wang TS; Ferrone S
Int J Cancer; 1991 Oct; 49(4):624-30. PubMed ID: 1917164
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule.
Matzku S; Kirchgessner H; Dippold WG; Brüggen J
Eur J Nucl Med; 1985; 11(6-7):260-4. PubMed ID: 4076233
[TBL] [Abstract][Full Text] [Related]
4. Modulation of melanoma-associated antigens by monoclonal antibodies as visualized by radioimmunoelectron microscopy and radioantibody binding assay.
Tilgen W; Matzku S; Kaufmann I; Engstner M; Brüggen J; Dippold W; Petzoldt D
Arch Dermatol Res; 1987; 279 Suppl():S116-26. PubMed ID: 3662602
[TBL] [Abstract][Full Text] [Related]
5. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
6. Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.
Rudnick SI; Lou J; Shaller CC; Tang Y; Klein-Szanto AJ; Weiner LM; Marks JD; Adams GP
Cancer Res; 2011 Mar; 71(6):2250-9. PubMed ID: 21406401
[TBL] [Abstract][Full Text] [Related]
7. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
Hamby CV; Chinol M; Palestro CJ; Manzo C; Ferrone S
Int J Cancer; 1998 Nov; 78(4):486-90. PubMed ID: 9797138
[TBL] [Abstract][Full Text] [Related]
8. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
Sung C; Shockley TR; Morrison PF; Dvorak HF; Yarmush ML; Dedrick RL
Cancer Res; 1992 Jan; 52(2):377-84. PubMed ID: 1728409
[TBL] [Abstract][Full Text] [Related]
9. Lack of comparability between binding of monoclonal antibodies to melanoma cells in vitro and localization in vivo.
McCready DR; Balch CM; Fidler IJ; Murray JL
J Natl Cancer Inst; 1989 May; 81(9):682-7. PubMed ID: 2709424
[TBL] [Abstract][Full Text] [Related]
10. Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
Br J Cancer; 1996 Feb; 73(4):457-64. PubMed ID: 8595159
[TBL] [Abstract][Full Text] [Related]
11. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
[TBL] [Abstract][Full Text] [Related]
12. Modes of binding and internalization of monoclonal antibodies to human melanoma cell lines.
Matzku S; Bröcker EB; Brüggen J; Dippold WG; Tilgen W
Cancer Res; 1986 Aug; 46(8):3848-54. PubMed ID: 3731060
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes.
Sikora LK; Pinto A; Demetrick DJ; Dixon WT; Urbanski SJ; Temple W; Jerry LM
Int J Cancer; 1987 Feb; 39(2):138-45. PubMed ID: 3804488
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
15. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
16. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
Temponi M; Gold AM; Ferrone S
Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
[TBL] [Abstract][Full Text] [Related]
17. Altered antigenicity of human monoclonal antibodies derived from human-mouse heterohybridomas.
Kan-Mitchell J; Andrews KL; Gallardo D; Mitchell MS
Hybridoma; 1987 Apr; 6(2):161-72. PubMed ID: 3552958
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH
Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653
[TBL] [Abstract][Full Text] [Related]
19. Preclinical and phase I studies of monoclonal antibodies in melanoma: application to boron neutron capture therapy of melanoma.
Hersey P
Pigment Cell Res; 1989; 2(4):264-72. PubMed ID: 2678081
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
